These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30310937)

  • 1. miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.
    Torabi S; Tamaddon M; Asadolahi M; Shokri G; Tavakoli R; Tasharrofi N; Rezaei R; Tavakolpour V; Sazegar H; Kouhkan F
    Immunogenetics; 2019 Feb; 71(2):87-95. PubMed ID: 30310937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells.
    Guan H; Singh UP; Rao R; Mrelashvili D; Sen S; Hao H; Zumbrun EE; Singh NP; Nagarkatti PS; Nagarkatti M
    Immunology; 2016 Apr; 147(4):488-98. PubMed ID: 26780721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.
    Baulina N; Kulakova O; Kiselev I; Osmak G; Popova E; Boyko A; Favorova O
    J Neuroimmunol; 2018 Apr; 317():67-76. PubMed ID: 29325906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of taurine-up-regulated gene 1 attenuates inflammation by sponging miR-9-5p via targeting NF-κB1/p50 in multiple sclerosis.
    Yue P; Jing L; Zhao X; Zhu H; Teng J
    Life Sci; 2019 Sep; 233():116731. PubMed ID: 31394128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
    Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
    J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
    Tavakolpour V; Shokri G; Naser Moghadasi A; Mozafari Nahavandi P; Hashemi M; Kouhkan F
    J Neuroimmunol; 2018 Dec; 325():79-86. PubMed ID: 30316680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients.
    Lindberg RL; Hoffmann F; Mehling M; Kuhle J; Kappos L
    Eur J Immunol; 2010 Mar; 40(3):888-98. PubMed ID: 20148420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
    Giuliani A; Lattanzi S; Ramini D; Graciotti L; Danni MC; Procopio AD; Silvestrini M; Olivieri F; Sabbatinelli J
    Mult Scler Relat Disord; 2021 Sep; 54():103126. PubMed ID: 34243103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-9-5p and miR-106a-5p dysregulated in CD4
    Majd M; Hosseini A; Ghaedi K; Kiani-Esfahani A; Tanhaei S; Shiralian-Esfahani H; Rahnamaee SY; Mowla SJ; Nasr-Esfahani MH
    Iran J Basic Med Sci; 2018 Mar; 21(3):277-283. PubMed ID: 29511494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human miR-26a-5p regulates the glutamate transporter SLC1A1 (EAAT3) expression. Relevance in multiple sclerosis.
    Potenza N; Mosca N; Mondola P; Damiano S; Russo A; De Felice B
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):317-323. PubMed ID: 28962897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the expression of mir-34a, mir-199a, mir-30c and mir-19a in peripheral blood CD4+T lymphocytes of relapsing-remitting multiple sclerosis patients.
    Ghadiri N; Emamnia N; Ganjalikhani-Hakemi M; Ghaedi K; Etemadifar M; Salehi M; Shirzad H; Nasr-Esfahani MH
    Gene; 2018 Jun; 659():109-117. PubMed ID: 29551498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 and miR20a-5p Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients.
    Ehtesham N; Khorvash F; Kheirollahi M
    J Mol Neurosci; 2017 Jan; 61(1):16-24. PubMed ID: 27752929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes.
    Ruhrmann S; Ewing E; Piket E; Kular L; Cetrulo Lorenzi JC; Fernandes SJ; Morikawa H; Aeinehband S; Sayols-Baixeras S; Aslibekyan S; Absher DM; Arnett DK; Tegner J; Gomez-Cabrero D; Piehl F; Jagodic M
    Mult Scler; 2018 Sep; 24(10):1288-1300. PubMed ID: 28766461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Expression of miR-326 in T Cell-derived Exosomes of Patients with Relapsing-remitting Multiple Sclerosis.
    Azimi M; Ghabaee M; Naser Moghadasi A; Izad M
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):108-113. PubMed ID: 30848579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.